American Well Corp (AMWL) Stock Price & Analysis
American Well Corp (AMWL) rose 0.37% to USD 10.81 as of July 25, 2026 at 03:07 UTC, according to Nexqual real-time market data.
AMWL last closed at USD 10.77; the session ranged USD 10.71–11.13 on volume of 73,712 shares. Market capitalization is $180.62M, with a 52-week range of USD 3.71–13.45 (NYQ). Source: Nexqual, July 25, 2026 at 03:07 UTC.
Key Statistics (as of July 25, 2026 at 03:07 UTC)
| Price | USD 10.81 |
|---|---|
| Change | ▲ 0.37% (up) |
| Previous Close | USD 10.77 |
| Open | USD 10.97 |
| Day Range | USD 10.71 – 11.13 |
| 52-Week Range | USD 3.71 – 13.45 |
| Volume | 73,712 shares |
| Market Cap | $180.62M |
| Exchange | NYQ |
Technical Analysis (AMWL)
Nexqual's technical model rates AMWL "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:07 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.32 (neutral) |
| vs SMA50 | Above (USD 9.23) |
| MACD | 0.78 (positive) |
Analyst Ratings (AMWL)
Wall Street analysts rate AMWL "Hold" based on 5 analysts, with a mean price target of USD 8.9 (range USD 6.5–16), per Nexqual as of July 25, 2026 at 03:07 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 8.9 |
| High Target | USD 16 |
| Low Target | USD 6.5 |
| Buy / Hold / Sell | 1 / 6 / 0 |
Earnings (AMWL)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD -0.6 |
| Revenue Estimate | $49.88M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.67 vs est -0.77 ▲ beat |
| 2025-12-31 | USD -1.13 vs est -1.6 ▲ beat |
| 2025-09-30 | USD -1.55 vs est -1.46 ▼ miss |
| 2025-06-30 | USD -0.72 vs est -1.11 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Financials & Fundamentals (AMWL)
| Total Revenue | $237.38M |
|---|---|
| Revenue Growth (YoY) | -17.90% |
| Gross Margin | +53.80% |
| Operating Margin | -23.59% |
| Profit Margin | -37.02% |
| ROE | -31.84% |
| Debt / Equity | 1.65 |
| Current Ratio | 3.09 |
| Total Cash | $180.00M |
| Total Debt | $3.96M |
| Free Cash Flow | $-11.78M |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Financial Health Score (AMWL)
Nexqual rates American Well Corp's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:07 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 54%, operating -24% |
| Balance Sheet | Strong — $180M cash vs $4M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$12M, burning cash |
| Efficiency | Critical — ROE -32%, ROA -13.4% |
Ownership (AMWL)
| Insider Ownership | +5.42% |
|---|---|
| Institutional Ownership | +46.01% |
| Shares Outstanding | 15.06M |
| Float | 11.72M |
| Short % of Float | +1.21% |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Leadership (AMWL)
American Well Corp is led by Ido Schoenberg (age 60), Chairman & CEO, per Nexqual as of July 25, 2026 at 03:07 UTC.
| Chairman & CEO | Ido Schoenberg (age 60) |
|---|---|
| Executive VP, COO & CFO | Mark J. Hirschhorn (age 60) |
| Chief Product & Technology Officer | Dan Zamansky (age 41) |
| Vice President of Accounting | Paul Francis McNeice (age 48) |
| Senior Vice President & Chief Sales Officer | Michael Miller |
Major Backers & Investors (AMWL)
Notable institutional backers of American Well Corp include Morgan Stanley, Senvest Management LLC, Cable Car Capital, LP, according to Nexqual as of July 25, 2026 at 03:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 7.68% |
| Senvest Management LLC | 7.55% |
| Cable Car Capital, LP | 6.66% |
| Acadian Asset Management. LLC | 2.7% |
| Renaissance Technologies | 1.29% |
| Fidelity | 0.98% |
| Rock Point Advisors, LLC | 0.9% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 7.48% |
| BlackRock | 2.6% |
| Geode Capital | 1.25% |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
From American Well Corp's Latest SEC 10-K Filing (filed 2026-02-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Amwell adheres to what we believe to be the highest security standards in the industry, using Auth0 with OAuth 2.0 SSO webRTC for in-browser video and Google's Healthcare API for secure and standardized data storage.
- We believe the Amwell Platform's ability to seamlessly integrate Amwell capabilities, client capabilities, and third-party capabilities versus forcing clients to either manage numerous point solutions or get locked into a single full stack vendor solution is another strong differentiator in our industry.
- Our differentiated approach empowers our clients to leverage the trust associated with their market-leading brands while we provide the core technology and clinical support to enable quality patient and member care.
- Interoperability The Amwell Platform is built on FHIR ("Fast Healthcare Interoperability Resources") – not an antiquated, proprietary data model that needs to be translated to HL7 standards.
Partnerships
- For example, our collaboration with Hello Heart supports cardiovascular disease prevention and management, The breadth of our ecosystem has enabled a deep understanding of health system and health plan workflows and reimbursement arrangements between our clients, allowing us to configure the Amwell Platform to meet their needs.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | USD 2.96 | ▲ 1.02% |
| FROG | JFrog Ltd. | USD 80.16 | ▲ 0.6% |
| NNOX | NANO-X IMAGING LTD | USD 0.9 | ▼ 8.46% |
| VRM | Vroom, Inc. | USD 7.09 | ▲ 0.85% |
| SDGR | Schrodinger, Inc. | USD 14.97 | ▼ 0.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:07 UTC. This page is informational and not investment advice.